Overview

Pregabalin (Lyrica) for the Treatment of Essential Tremor

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
This will be a multi-site, prospective, double-blind, randomized, placebo-controlled, crossover trial conducted over 6 months to assess the effectiveness and safety of PGB to treat symptoms of ET.
Phase:
Phase 4
Details
Lead Sponsor:
University of South Florida
Collaborator:
Pfizer
Treatments:
Pregabalin